Detalles de la búsqueda
1.
Application of AOPs to assist regulatory assessment of chemical risks - Case studies, needs and recommendations.
Environ Res
; 217: 114650, 2023 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36309218
2.
Assessment of the endocrine disrupting properties of bisphenol AF: a case study applying the European regulatory criteria and guidance.
Environ Health
; 20(1): 48, 2021 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33894771
3.
Testing and refining the Science in Risk Assessment and Policy (SciRAP) web-based platform for evaluating the reliability and relevance of in vivo toxicity studies.
J Appl Toxicol
; 38(12): 1460-1470, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29806706
4.
A call for action: Improve reporting of research studies to increase the scientific basis for regulatory decision-making.
J Appl Toxicol
; 38(5): 783-785, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29297199
5.
Combining web-based tools for transparent evaluation of data for risk assessment: developmental effects of bisphenol A on the mammary gland as a case study.
J Appl Toxicol
; 37(3): 319-330, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27488142
6.
A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals.
Environ Health
; 15(1): 74, 2016 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27412149
7.
Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals.
Rev Endocr Metab Disord
; 16(4): 273-87, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26847432
8.
Facilitating the use of non-standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reporting.
J Appl Toxicol
; 34(6): 607-17, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24481642
9.
Exploring a mechanism-based approach for the identification of endocrine disruptors using Adverse Outcome Pathways (AOPs) and New Approach Methodologies (NAMs) : A perfluorooctane sulfonic acid case study.
Toxicology
; 504: 153794, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38580097
10.
Building an adverse outcome pathway network for estrogen-, androgen- and steroidogenesis-mediated reproductive toxicity.
Front Toxicol
; 6: 1357717, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601197
11.
Beyond chemicals: Opportunities and challenges of integrating non-chemical stressors in adverse outcome pathways.
ALTEX
; 41(2): 233-247, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37980615
12.
Applying a modified systematic review and integrated assessment framework (SYRINA) - a case study on triphenyl phosphate.
Environ Sci Process Impacts
; 26(2): 380-399, 2024 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38205707
13.
SciRAPnano: a pragmatic and harmonized approach for quality evaluation of in vitro toxicity data to support risk assessment of nanomaterials.
Front Toxicol
; 5: 1319985, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38046400
14.
Development of a data-driven approach to Adverse Outcome Pathway network generation: a case study on the EATS-modalities.
Front Toxicol
; 5: 1183824, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37229356
15.
Protocol for designing INVITES-IN, a tool for assessing the internal validity of in vitro studies.
Evid Based Toxicol
; 1(1): 1-15, 2023 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38264543
16.
Development of an adverse outcome pathway for intrahepatic cholestasis of pregnancy.
Curr Res Toxicol
; 3: 100065, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35243364
17.
Systematic evaluation of the evidence for identification of endocrine disrupting properties of Bisphenol F.
Toxicology
; 476: 153255, 2022 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35811010
18.
Assessment of endocrine disruptive properties of PFOS: EFSA/ECHA guidance case study utilising AOP networks and alternative methods.
EFSA J
; 20(Suppl 1): e200418, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35634558
19.
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework.
J Clin Med
; 11(15)2022 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35956081
20.
COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop.
ALTEX
; 39(2): 322335, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032963